Re: TNBC no longer active?

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

tada

Rank: President [?]

Points: 7750 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: TNBC no longer active?

in response to

TNBC no longer active?

jonzobot

posted on Jun 28, 2023 12:10AM

jonzobot - Always keep in mind that ZEL does not control any of the trials they are in. Every trial is controlled by third parties, Newsora or educational institutions.